| Reference | Number and entry criteria | Intervention | Duration | Age | Outcomes | Results | Adverse effects | Quality |
| Taken before sexual activity | ||||||||
| Segraves et al, 1993 USA | 29 men <1 minute or before 8 penile-vaginal strokes | Clomipramine 25 mg 6 hours before coitus parallel group | 10 coital experiences | 47 ± 10.2 placebo 45 ± 7.5 clomipramine | Men achieving at least 2 minutes intravaginal latency | Intravaginal latency 6.1 minutes clomipramine 0.9 minutes placebo | 2/10 erectile difficulties with clomipramine | r = 1 db = 2 w = 0 |
| Haensel et al, 1996 USA and Holland | 8 men premature ejaculation 6 men with erectile dysfunction and premature ejaculation 8 controls | Placebo or 25 mg clomipramine 12 to 24 hours before sexual activity cross-over | Two 3-week periods | 42 (range 31 to 62) 41 (26 to 52) 41 (26 to 52) | Intravaginal latency plus others | Intravaginal latency increased from 2 minutes on placebo to 8 minutes with clomipramine in men with premature ejaculation, no change in men with additional erectile dysfunction (about 2 minutes) and increased latency in normal controls from 9 to 11 minute | No ejaculation failures noted | r = 1 db = 2 w = 1 |
| Biri et al, 1998 Turkey | 37 men latency <1 minute | Sertraline 50 mg or placebo in the evening parallel group | 4 weeks | 31 (range 21 to 54) | Intravaginal latency | Median intravaginal latency 0.7 minutes baseline 1.9 minutes placebo 5.4 minutes sertraline | No ejaculation failures noted | r = 1 db = 2 w = 1 |
| Strassberg et al, 1999 USA and Holland | 23 premature ejaculation <2 minutes 11 control subjects | Clomipramine 50 mg or placebo 4-6 hours before sexual activity cross-over | Two 2-week periods | 46 (range 21 to 73) | Intravaginal latency | Mean intravaginal latency 0.9 minutes on placebo 3.8 minutes on clomipramine Control latency was 8 minutes increased to 11 minutes on clomipramine in 4 subjects | No ejaculation failures noted | r = 1 db = 2 w = 1 |
| McMahon & Touma, 1999 study 1 | 26 men with intravaginal latency <1 minute | Paroxetine 20 mg or placebo 4-6 hours before sexual activity cross-over | Two 4-week periods with 3 week washout | 40 (range 19 to 55) | Intravaginal latency and coitus frequency | Median intravaginal latency 0.3 minutes baseline 0.5 minutes placebo 3.2 minutes paroxetine | No ejaculation failures noted | r = 1 db = 0 w = 0 |
| McMahon & Touma, 1999 study 2 Australia | 42 men with intravaginal latency <1 minute | Paroxetine 10 mg daily for 2 weeks then 20 mg as needed 4-6 hours before sexual activity for 4 weeks or placebo in a similar schedule cross-over | Two 7-week periods with 3 week washout | 41 (range 20 to 51) | Intravaginal latency and coitus frequency | Median intravaginal latency 0.5 minutes baseline 0.8 minutes placebo 6.0 minutes paroxetine | 3 ejaculation failures with paroxetine | r = 1 db = 0 w = 0 |
| Daily dosing | ||||||||
| Waldinger et al, 1994 Holland | 17 men with intravaginal latency <2 minutes in more than 50% coital attempts | Paroxetine or placebo 20 mg daily for 1 week, then 40 mg daily for 5 weeks parallel group | 6 weeks | 40 (range 24 to 48) | Latency time | Paroxetine (n=6) latency 10 minutes (5-20) 6/6 >5 min Placebo (n=8) latency 0.25 minutes (0-2) 0/8 >2 min | No significant differences | r = 1 db = 2 w = 1 |
| Mendels et al, 1995 USA | 52 men with intravaginal latency <1 minute in more than 50% coital attempts | Sertraline or placebo 50-200 mg daily titrated over 3 weeks parallel group | 10 weeks | Range 25 to 52 years | Intravaginal latency plus others | Mean intravaginal latency at endpoint 5.4 minutes sertraline 1.8 minutes placebo | Ejaculation failure 5/26 sertraline 0/26 placebo | r = 2 db = 2 w = 1 |
| Althof et al, 1995 USA | 15 men with self-reported mean time to ejaculation <4 minutes | Placebo, 25 mg or 50 mg clomipramine daily cross-over | Sufficient for at least 5 occasions of intercourse | 38 (range 23 to 56) | Intravaginal latency plus others | Mean intravaginal latency 1.3 minutes at baseline 3.4 clomipramine 25 mg 7.0 clomipramine 50 mg | No ejaculation failures noted | r = 1 db = 1 w = 1 |
| Kara et al, 1996 Turkey | 17 men with intravaginal latency <2 minutes in more than 50% coital attempts | Placebo or fluoxetine 20 mg daily for 1 week, then 40 mg daily parallel group | 4 weeks | 32 (range 15 to 50 years) all married | Intravaginal latency | Mean pre-treatment intravaginal latency was 0.5 minutes. After 4 weeks treatment it was 3 minutes with fluoxetine and 1 minute in the placebo group. | None mentioned | r = 1 db = 1 w = 0 |
| Waldinger et al, 1997 Holland | 34 men with primary premature ejaculation with intravaginal latency <1 minute | Paroxetine 20 mg or 40 mg daily parallel group | 8 weeks | 44 (range 23 to 57) | Intravaginal latency | Median intravaginal latency 0.2 minutes (0-0.5) baseline 5.0 minutes (0.2 to 30) 8 weeks on 20 mg 9.0 minutes (1 to 20) 8 weeks on 40 mg | Ejaculatory failure 2/17 20 mg 4/17 40 mg | r = 1 db = 2 w = 1 |
| McMahon, 1998 Australia | 37 men with latency <1 minute | Sertraline or placebo 50 mg daily cross-over | Two 4-week periods with 4 week washout | 41 (range 19 to 70) | Intravaginal latency and coitus frequency | Median intravaginal latency 0.6 minutes baseline 1.0 minutes placebo 3.2 minutes sertraline | 2/37 ejaculatory failures | r = 1 db = 2 w = 1 |
| Kim & Seo, 1998 Korea | 36 men with latency <2 minutes | Fluoxetine 40 mg Sertraline 100 mg Clomipramine 50 mg placebo cross-over | Four 4-week periods with 1 week washout between | 44 (range 30 to 60) | Intravaginal latency | Median intravaginal latency after 4 weeks 0.8 minutes baseline 2.3 minutes placebo 2.3 minutes fluoxetine 4.3 minutes sertraline 5.8 minutes clomipramine | No ejaculation failures noted | r = 0 db = 2 w = 1 note: does not state randomised, but implied in text |